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OBJECTIVE: This study investigated whether birthweight is linked to an RESULTS: Significantly increased ORs were observed in the univariate
increased risk of the development of systemic sclerosis.
STUDY DESIGN: This was a multicenter case-control study with
perinatal data that were obtained from 332 cases with systemic
sclerosis and 243 control subjects. Birthweight was treated as a
dichotomous variable (<2500 g vs 2500 g); low birthweight was
defined as a weight<2500 g; small for gestational age was defined as
birthweight<10th percentile for gestational age adjusted for sex. The
relationship between systemic sclerosis and both low birthweight and
small for gestational age was expressed with the crude (univariate
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1.39e5.05) and small for gestational age (OR, 2.60; 95% CI,
1.34e5.32) subjects. Similarly increased risks were confirmed for
both conditions in the multivariate analysis (OR, 3.93; 95% CI,
1.92e8.07; and OR, 2.58; 95% CI, 1.28e5.19), respectively.
CONCLUSION: Low birthweight and small for gestational age at birth
are risk factors for the adult onset of systemic sclerosis.
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immune disease characterized by
vascular obliteration, excessive extracel-
lular matrix deposition, and ﬁbrosis of
the connective tissues.1,2 Estimates of the
disease’s prevalence and incidence range
from 50-300 cases per million people
and 2.3e22.8 cases per million people
per year, respectively.3 Women are more
likely to experience SSc than are men,
with reported ratios ranging from
3:1e14:1; a slightly increased suscepti-
bility has also been reported among
black patients.4The cause of SSc has remained elusive
despite intense investigation, although
there is convincing evidence that genetic
factors contribute to its onset and devel-
opment. Genetics studies suggest that SSc
is a complex polygenic disease. Candidate
gene studies have identiﬁed critical
immunoregulatory genes and gene re-
gions (in particular, the human leukocyte
antigen region) as susceptibility genes for
the development of the disease.5 How-
ever, even though the genetic contribu-
tion to the disease has been shown, it now
seems that environmental agents also
play a critical role.6 The link betweenpi, and De Masi) and
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DECEMBER 2015 Amerigenes and environment is represented
by the new ﬁeld of research of epige-
netics: the study of heritable changes in
genes and gene expression that do not
involve DNA nucleotide sequences.
Epigenetic modiﬁcations include DNA
methylation, histone modiﬁcations, and
microRNA expression.7 In humans,
cytosine methylation and its modiﬁca-
tions in response to maternal diet is 1 of
the most widely studied epigenetic
modiﬁcations and is a sign of adverse
exposure in utero. Interestingly, differ-
entially methylated regions that are
dependent on themother’s diet have been
identiﬁed in the liver of female offspring,
which represents potential marks of
developmental programming that may
link the intrauterine environment to
metabolic health later in life.8
This is an epidemiologic study that
was inspired by the robust work of David
Barker9 and others, who postulated that
the environment can modify the devel-
opmental trajectory of an individual even
during the ﬁrst stages of life, thus
laying the foundations for disease in
adulthood (the so-called fetal program-
ming theory). In fact, it is possible that
adverse environmental conditions duringcan Journal of Obstetrics& Gynecology 839.e1
Research Obstetrics ajog.orgfetal growth could alter developmental
processes and explain how a single ge-
notype can give rise to different pheno-
types (developmental plasticity).10 This
approach has been shown to be valid
particularly for chronic diseases such as
cardiovascular disease,11 metabolic dis-
eases (including diabetes mellitus),12
osteoporosis, and some forms of can-
cer.13 In line with this theory, several
studies have shown that low birthweight
(LBW), which can be indicative of
exposure to an adverse fetal environment
during speciﬁc stages of gestation (so-
called “critical” periods, when rapid cell
division takes place), led to an increased
risk of chronic diseases in adulthood
because of programming of the neuro-
endocrine setting, antioxidant defenses,
inﬂammation, and the immune system
itself.14,15
This study was based on the hypothesis
that the immune system is subject to
developmental plasticity during its
maturation, with a real possibility that
disruptors in the early fetal environment
may impair its function by epigenetic
mechanisms, thereby increasing the onset
of chronic autoimmune diseases.16,17 The
main goal was to evaluate whether a
signiﬁcant correlation exists between
birthweight and/or gestational age and
the subsequent development of SSc.
MATERIALS AND METHODS
A multicenter case-control study was
conducted from June 2012 to November
2013; 332 consecutive prevalent cases of
SSc were enrolled from the rheumato-
logic outpatient clinics of the following
hospitals: Careggi University Hospital of
Florence, La Sapienza University Hos-
pital of Rome, the IRCCS Foundation
and San Matteo University Hospital of
Pavia, and the University Hospital of
Ancona. The study was approved by the
Ethics Committee of the Meyer Chil-
dren’s Hospital, University of Florence.
Cases were deﬁned as patients affected
by SSc according to the recent classiﬁ-
cation developed by the American
College of Rheumatology/European
League.18 Two hundred forty-three
consecutive control subjects were
recruited from the surgical outpatient
clinic of the Careggi University Hospital839.e2 American Journal of Obstetrics& Gynecolof Florence during the same period.
Control subjects were matched to cases
with the use of a frequency-matching
method to obtain a similar age/sex dis-
tribution in both groups.
To collect demographic and perinatal
information, a standardized question-
naire was created, and the patients were
interviewed by trained medical
personnel. The following information
was collected: patient identiﬁcation, sex,
age, birthweight, gestational age at birth,
their mother’s age at birth, whether they
were breastfed, and the mother’s smok-
ing habit. Birthweight and gestational
age were recorded as continuous vari-
ables; when subjects did not recall exact
values, they were asked to categorize
birthweight as <2500, 2500-3999, or
4000 g and gestational age as <37,
37-41, or >41 weeks. With regard to the
occupational histories of patients and
control subjects, particular attention was
given to exposure to crystalline silica,
organic solvents, welding fumes, epoxy
resins, and pesticides.19 To minimize
recall bias and ensure the validity of the
approach, the data that were collected
were compared with the data recorded in
the clinical charts, even if this was
possible only in 40 of the patients (12%)
and 24 of the control subjects (10%)
because of a lack of available records,
especially in the case of older subjects.
Moreover, the interview was repeated
1 month later in a randomized group of
40 patients and 40 control subjects to
assess the level of uncertainty that had
been attributed to recall.
The following disease characteristics
were obtained directly from the hospital
databases for all patients with a diagnosis
of SSc: auto-antibody pattern (antinu-
clear antibodies, anticentromere anti-
bodies, anti-Scl-70), age at disease onset,
type of disease (diffuse cutaneous,
limited cutaneous), organ involvement
(articular, cardiac, gastrointestinal, pul-
monary), and the presence of pulmo-
nary hypertension and digital ulceration.
The exclusion criteria for both patients
and control subjects were refusal to
participate, the presence of chronic dis-
eases (such as coronary heart disease and
related disorders, stroke, hypertension,
and type 2 diabetes mellitus14), andogy DECEMBER 2015occupation-related SSc risk factors (in
particular organic solvents, silica, white
spirit, welding fumes, and epoxy
resins).19 Furthermore, the presence of
other autoimmune diseases was an
exclusion criterion for patients with SSc;
the presence of any autoimmune disease
was an exclusion criterion for control
subjects. The Regional Center of Rare
Diseases of the Meyer Children’s Hos-
pital, University of Florence, developed
the research protocol, supervised the
data collection and performed the sta-
tistical data analysis.
LBW was deﬁned as a weight at birth
of <2500 g, as per the International
Statistical Classiﬁcation of Diseases and
Related Health Problems, 10th revision.
The term small for gestational age (SGA)
refers to infants whose birthweights and/
or lengths are at least 2 standard devia-
tion units less than the mean for gesta-
tional age.20 In clinical practice, SGA
commonly is deﬁned as a birthweight
<10th percentile for gestational age and
sex relative to the population standard; it
is used as a measurable proxy for intra-
uterine growth restriction and later
health risks.21
The study population was divided
according to birthweight (<2500,
2500, or 4000 g) and gestational age
(preterm, <37 weeks; at term, 37-41
weeks; postterm, >41 weeks). The as-
sociation between LBW and SSc and
between SGA and SSc was expressed
with the odds ratio (OR) calculated with
a univariate analysis that considered
2 birthweight groups (<2500 and2500
g). Two multivariate analyses were then
performed to test the associations
among all 3 birthweight groups (<2500,
2500-3999, and 4000 g) and both SGA
conditions, with the risks for SSc
adjusted for other confounding factors.
A sample size of 318 cases and 212
control subjects was estimated, with the
assumption of a 5% exposure among
control subjects and a minimum appre-
ciable OR of 3 (alpha error, 5%; power,
90%). The statistical analysis was per-
formed with the Stata software (version
10; StataCorp LP, College Station, TX).
Eleven percent of the subjects in
both groups (66/575) were excluded
because of uncertainty about their
TABLE 1
Study population
Variable
Cases
(n[ 332)
Control
subjects
(n[ 243) P value
Total
(n[ 575)
Mean age, y  SD 59.1  13.2 56.1  6.2 < .05 58.1  11.5
Maternal age at delivery, y  SD 29.3  6.0 27.9  5.8 < .05 28.7  5.9
Sex, n (%) .07
Male 15 (4.5) 18 (7.4) 33 (5.7)
Female 317 (95.5) 225 (92.6) 542 (94.3)
Birthweight, n (%) < .05
Missing 51 (15.4) 15 (6.2) 66 (11.5)
<2500 g 46 (13.9) 16 (6.6) 62 (10.8)
2500 g 235 (70.8) 212 (87.2) 447 (77.7)
Gestational age at birth, n (%) .66
Missing 15 (4.5) 2 (0.9) 15 (2.6)
Preterm 9 (2.7) 4 (1.6) 13 (2.3)
Term 299 (90.1) 230 (94.6) 531 (92.3)
Postterm 9 (2.7) 7 (2.9) 16 (2.8)
Small for gestational age, n (%) < .05
Missing 57 (17.2) 15 (6.2) 72 (12.5)
Yes 40 (12.0) 14 (5.8) 54 (9.4)
No 235 (70.8) 214 (88.1) 449 (78.1)
Breastfeeding, n (%) .41
Missing 108 (32.5) 4 (1.7) 112 (19.5)
Yes 202 (60.8) 217 (89.3) 419 (72.9)
No 22 (6.7) 22 (9.0) 44 (7.6)
Mother’s smoking habit, n (%) .29
Missing 107 (32.2) 7 (2.9) 114 (19.8)
Yes 9 (2.7) 12 (4.9) 21 (3.6)
No 216 (65.1) 224 (92.2) 440 (76.5)
Disease subtype, n (%)
Missing 13 (3.9)
Limited cutaneous systemic
sclerosis
246 (74.1)
Diffuse cutaneous systemic
sclerosis
73 (22.0)
Antibodies, n (%)
Missing 96 (28.9)
Anticentromere antibodies 133 (40.1)
Scl70 100 (30.1)
Anticentromere antibodies þ Scl70
(topoisomerase I)
3 (0.9)
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6.2% of control subjects); the gestational
age was uncertain in 4.5% of case studies
and 0.0% of the control group.
RESULTS
The clinical characteristics of the study
population are presented in Table 1. The
expected sex distribution of disease and
frequency matching that was adopted for
the enrolled control subjects demon-
strated a high prevalence of female cases
in the study population compared with
male cases. The age comparison between
case studies and control subjects showed
that the mean age of patients with SSc
was slightly higher in the control group.
Mothers of patients with SSc were
slightly older than the control subjects at
the time of delivery.
It was observed that LBW and SGA
were more prevalent in subjects with SSc
than in the control subjects (13.9% vs
6.9% and 12.0% vs 5.8%, respectively),
with a less pronounced difference
regarding preterm births (2.7% vs
1.6%). Table 2 contains the ORs of SSc
that were evaluated as a univariate
analysis for LBW, SGA, maternal age at
delivery, gestational age, breastfeeding,
and the mother’s smoking behavior
during pregnancy. SSc was more preva-
lent in LBW infants than in non-LBW
infants (OR, 2.59; 95% conﬁdence in-
terval [CI], 1.39e5.05). When the anal-
ysis was limited to female subjects only,
the OR rose to 2.90 (95% CI,
1.51e5.89). A similar result was found
when exposure to SGA was considered
(OR, 2.60; 95% CI, 1.34e5.32,
increasing to OR, 2.73; 95% CI,
1.38e5.73 in female subjects). Both
estimated risks were statistically signiﬁ-
cant (P < .05). The results showed that
advanced maternal age (>34 years) was
associated with an increased risk of SSc
(OR, 2.28; 95% CI, 1.34e3.88). The
mother’s age at the time of delivery
therefore can be considered an addi-
tional, independent risk factor for the
disease. Conversely, the breastfeeding
and smoking habits of the mothers of
patients with SSc were not associated
with a signiﬁcantly increased risk of SSc.
Table 3 shows the multivariate anal-
ysis limited to female subjects that,DECEMBER 2015 American Journal of Obstetrics& Gynecology 839.e3
TABLE 2
Odds ratio of systemic sclerosis: univariate analysis
Variable Cases, n
Control
subjects, n
Odds ratio (95%
confidence interval)
Birthweight, g
<2500 46 16 2.59 (1.39e5.05)
2500 235 212 1.00
Birthweight (female only), g
<2500 46 14 2.90 (1.51e5.89)
2500 224 198 1.00
Small for gestational age
Yes 40 14 2.60 (1.34e5.32)
No 235 214 1.00
Small for gestational age (female only)
Yes 40 13 2.73 (1.38e5.73)
No 224 199 1.00
Maternal age at delivery (female only), y
<25 69 68 1.00
25-29 100 79 1.25 (0.80e1.95)
30-34 74 46 1.58 (0.96e2.61)
>34 74 32 2.28 (1.34e3.88)
Gestational age (female only), wk
37-41 284 213 1.0
<37 9 3 2.28 (0.61e8.53)
>41 9 6 1.14 (0.40e3.25)
Breastfeeding
Yes 202 217 0.93 (0.50e1.73)
No 22 22 1.0
Breastfeeding (female only)
Yes 189 202 1.07 (0.54e2.14)
No 20 23 1.0
Mother’s smoking habit
Yes 9 12 0.78 (0.28e2.06)
No 216 224 1.0
Mother’s smoking habit (female only)
Yes 8 11 0.74 (0.25e2.07)
No 203 207 1.0
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models, shows the independent effect of
birthweight grouped into different clas-
ses: birthweight (overweight, 4000 g;839.e4 American Journal of Obstetrics& Gynecolunderweight, <2500 g; and normal
weight, 2500-4000 g), gestational age
(term, preterm, and postterm), age of
cases and control subjects, and maternalogy DECEMBER 2015age at delivery. The multivariate analysis
shows that the odds of disease in the
female LBW group are approximately
4 times higher than in the normal
birthweight group. No additional
risk was observed in subjects with
birthweight >4000 g as compared with
subjects of normal weight at birth (2500-
3999 g). SGA status increases the OR of
disease approximately 2.6-fold in the
multivariate analysis that includes the
age of cases and control subjects and
maternal age at delivery. In both models,
the patient’s age is an independent risk
factor for disease, with a risk of 4%
(model 1) and 5% (model 2) for each
additional year (Table 3).
Table 4 shows several disease features
that are related to LBW and SGA status.
No correlation was found between LBW
and SGA with the age at the onset of
lung, gastrointestinal, articular, or car-
diac involvement or the presence of
ulcers and pulmonary hypertension in
patients with SSc. Within the context of
the high correlation between LBW and
adult-onset SSc, there is an increased risk
of the limited form compared with the
diffuse form of the disease (OR, 0.36;
95% CI, 0.10e0.97). The compliance
between the questionnaire data and the
data recorded in the clinical charts was
high and did not differ between cases
(93%) and control subjects (95%).
Furthermore, the repetition of the
interview resulted in an accuracy of 95%;
76 of 80 subjects reported exactly the
same data in both interviews.
The incidence of missing data was al-
ways higher for cases than control sub-
jects because of a lower percentage of
survival of subjects’ parents (an impor-
tant source of information). Simulating a
situation in which the missing data
proved to be opposed to the study’s pri-
mary hypothesis (LBWand SGA vs SSc),
we attributed a high weight (>2500 g)
to all patients of the case group with
missing weight data and still obtained a
statistically signiﬁcant OR of 2.1.
COMMENT
The principal ﬁnding of the study was
that LBW and SGA status represent risk
factors for the development of SSc at an
adult age, with a higher incidence for
TABLE 3
Odds ratio of systemic sclerosis: multivariate analysis (female only)
Parameter Odds ratio 95% confidence interval
Model 1
Birthweight, g
2500-3999 1.00
<2500 3.93 1.92e8.07
4000 1.06 0.57e1.98
Age (by year) 1.04 1.02e1.06
Gestational age, wk
37-41 1.00
<37 or >41a 2.22 0.88e5.59
Maternal age at delivery, y
<25 1.00
25-29 1.23 0.71e2.14
30-34 1.53 0.83e2.83
>34 2.23 1.16e4.26
Model 2
Small for gestational age
No 1.00
Yes 2.58 1.28e5.19
Age (by year) 1.05 1.03e1.07
Maternal age at delivery, y
<25 1.00
25-29 1.18 0.72e1.93
30-34 1.46 0.84e2.56
>34 2.01 1.11e3.63
a Cases with gestational age<37 and>41 weeks were grouped together on the basis of the results of the univariate analysis
(Table 2), which showed no statistical difference between each of these groups and the reference category.
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that no additional risk was observed in
subjects with high birthweight, in
contrast with other epidemiologic
studies that have demonstrated a signif-
icant correlation between a birthweight
of 4000 g and adult-onset rheumato-
logic autoimmune diseases such as
Sjogren’s syndrome22 and rheumatoid
arthritis.23,24 An increased risk was also
observed for systemic lupus erythema-
tosus for both high birthweight and
premature birth.25 These ﬁndings seem
to indicate that both conditions (LBW,
<2500 g) and high birthweight (4000
g) may inﬂuence fetal developmental
plasticity and result in a chronic auto-
immune disease in adulthood.
From a clinical standpoint, this study
allows LBW to be considered as an
additional risk factor with respect to
those already known for the develop-
ment of SSc.19 It is clear that prematurity
or intrauterine growth retardation are
not limited to conditioning health in the
short-term but can cause various dis-
eases over the long-term, which include
hypertension, diabetes mellitus, obesity,
and heart disease; we can add SSc, which
is part of the broader spectrum of auto-
immune rheumatic diseases, to this list.
Themechanisms that link birthweight,
gestational age, and autoimmune disease
can be inserted in a growing body of ev-
idence that highlights the importance of
intrauterine insults in programming the
developing immune system. An adverse
intrauterine environment seems to cause
thymus dysfunction and subsequent
long-term immunologic deregulation,26
and it was signiﬁcantly more likely to
ﬁnd incomplete thymus involution in SSc
and patients with rheumatoid arthritis
than in a nonautoimmune control
group.27 Several studies have demon-
strated that cesarean delivery, which
often is associated with stressful intra-
uterine conditions, is linked to short-
term consequences for the newborn
infant and increased risk of asthma, al-
lergies, and type 1 diabetes mellitus in
adulthood.28,29 Cesarean delivery seems
to perturb the neonate’s microbiome,
and the lack of a labor-induced stress
response negatively affects immune
activation; these mechanisms lead toepigenetic changes and therefore a
predisposition to immune-related disor-
ders.30 For example, DNA hyper-
methylation was found in hematopoietic
stem cells of infants born by cesarean
delivery at term.31 Another postulated
programming mechanism involves acti-
vation of the maternal hypothalamic-
pituitary-adrenal axis (HPA) in response
to nutritional stress with consequent
high fetal exposure to glucocorticoids.
This hormone elevation could give rise
to an early shift from cell proliferation
to cell differentiation in the immune
system, with an inappropriate pattern
of growth for the stage of development
and possible adverse consequencesDECEMBER 2015 Amerimuch later in life.32,33 Altered HPA ac-
tivity was reported to be a possible
underlying mechanism in an animal
model study that found a transgenera-
tional effect of maternal treatment
with dexamethasone, a common clini-
cal practice in pregnancies at risk of
preterm birth: ﬁrst ﬁlial generation and
second ﬁlial generation ewe lamb
offspring showed an increased baseline
but reduced stimulated HPA activity.34
Another pathway through which mater-
nal nutrition has broad relevance for
immune-mediated diseases is repre-
sented by the link between a lack of
omega-3 fatty acids during pregnancy
and the suppression of interleukin 13can Journal of Obstetrics& Gynecology 839.e5
TABLE 4
Odds ratio: female and cases only
Variable
Odds ratio (95% confidence interval)
Low birthweight/
no low birthweight
Small for gestational
age/no small for
gestational age
Type of disease: systemic sclerosis
Limited cutaneous 1.0 1.0
Diffuse cutaneous 0.36 (0.10e0.97) 0.43 (0.12e1.18)
Age of disease onset, y
<30 1.0 1.0
30-59 1.68 (0.61e4.58) 1.81 (0.60e5.47)
>59 1.71 (0.47e6.19) 2.37 (0.61e9.29)
Pulmonary hypertension
No 1.0 1.0
Yes 1.22 (0.34e3.68) 1.54 (0.42e4.73)
Ulcers
No 1.0 1.0
Yes 0.62 (0.26e1.35) 0.67 (0.27e1.53)
Pulmonary involvement
No 1.0 1.0
Yes 1.10 (0.53e2.32) 1.38 (0.63e3.15)
Gastrointestinal involvement
No 1.0 1.0
Yes 1.53 (0.69e3.59) 1.67 (0.71e4.25)
Cardiac involvement
No 1.0 1.0
Yes 1.53 (0.15e8.67) 1.84 (0.17e10.52)
Articular involvement
No 1.0 1.0
Yes 0.56 (0.24e1.23) 0.61 (0.25e1.39)
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alter T helper cell 2 and 1 balance at
birth with a pronounced T helper cell 2
deviation. This mechanism could be the
basis for a predisposition to allergic dis-
eases in adult life.35 In addition to
nutritional shortage, early alterations to
the immune system could also result
from nutritional excesses; for example,
regulators that are related to inﬂamma-
tory and cytokine signaling were found
to be activated signiﬁcantly in obese
women.839.e6 American Journal of Obstetrics& GynecolFurthermore, mother obesity seems to
up-regulate genes that are implicated in
the development of the hippocampus,
cerebral cortex, and amygdala, which re-
sults in neurodegeneration and decreased
survival of sensory neurons that might
inﬂuence neurodevelopment.36 Entri-
nger et al37 assessed leukocyte telomere
length in cord blood peripheral cells and
observed a signiﬁcant, independent,
linear effect of pregnancy-speciﬁc stress
on newborn infant leukocyte telomere
length. These ﬁndings indicate thatogy DECEMBER 2015psychologic stress during pregnancy may
program the developing telomere biology
system,which is 1 of the predictors of age-
related diseases and death.
There is persuasive evidence that
supports a signiﬁcant contribution of
epigenetic dysregulation to the origin of
SSc: environmental agents may conduce
epigenetic modiﬁcations to genes that
are involved in the immune system and
therefore break tolerance, induce self-
antigen abnormality, and ﬁnally trigger
immune reactions.38 As proof of this,
alterations in DNA methylation, histone
code modiﬁcations, and changes in
microRNA expression levels have been
observed in different cell lines (ﬁbro-
blasts, lymphocytes, and endothelial
cells) of patients with SSc.39,40 One of the
main recognized environmental risk
factors for SSc remains exposure to sil-
ica, but other occupational factors19 and
viral agents41 could also contribute to
SSc pathogenesis. Finally, it is now well-
known that endothelial cell injury is an
early event in SSc pathogenesis, and
abnormal vasoreactivity is thought to
result from endothelial cell malfunction,
with an imbalance favoring vasocon-
striction.42 Endothelial progenitor cells
(EPCs) are immature cells that derive
from bone marrow and proliferate,
migrate, and home to sites of neo-
vascularization, differentiating into
mature endothelial cells in situ; EPCs
play a critical role in vascular repair and
new blood vessel formation. A recent
study demonstrated that LBW preterm
neonates show an alteration of EPC
function with subsequent impaired
angiogenic capacity as compared with
full-term neonates. Furthermore, the
angiogenic defect of LBW endothelial
colony-forming cells was conﬁrmed in
mice by their inability to form robust
capillary networks.43
Regarding the research implications of
the study, further research is needed to
clarify the pathogenic links that could
explain the correlation between birth-
weight and the development of this
autoimmune disease, in particular the
mechanisms that result from a complex
interplay among the factors of genetic
susceptibility, environmental exposure,
and epigenetic modiﬁcations. On the
ajog.org Obstetrics Researchbasis of the identiﬁcation of speciﬁc
epigenetic mechanisms, it would be
possible to develop appropriate diag-
nostic and therapeutic strategies as part
of a personalized/precision medicine
approach that would improve the clin-
ical outcome of patients with SSc.
This is the ﬁrst study that has aimed to
ﬁnd a link between SSc and early life
events in the context of epigenetics.
Although the study has the strength of
having been conducted with a large
enrolled study population, the potential
existence of several inaccuracies in the
data collected cannot be ruled out,
because they come from a cohort of
births in the 1950s. However, the inac-
curacies of this study were attenuated by
a cross-check of the interview responses
with perinatal data in clinical charts and
the performance of a repeat interview,
which are methods that have been vali-
dated in other studies.44-46
There is extensive evidence that sub-
jects with LBWare at a greater risk of the
development of many uncommunicable,
chronic adult diseases. The results
described here show a strong association
between LBW and adult-onset of SSc.-
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